The consortium of COVID-X announces the launch of a unique acceleration program in Europe – a 2-year initiative that will invest 4 million € to fast-track to market 30+ European data technology solutions with the potential to overcome COVID-19 Challenges.
COVID-19 pandemic is hitting with force. Europe has passed the threshold of 250,000 deaths since February 2020. COVID-X takes the battle against coronavirus to a new level by bridging the gap between the European digital sector and the healthcare system. The program will unlock the full capacity of Artificial Intelligence and Data Technology solutions fighting COVID-19 Challenges, validating and scaling up results to save lives.
COVID-X will fund Technology Companies and Healthcare Providers to fast-track data-driven solutions with the capacity to overcome challenges in Diagnosis, Prognosis and Follow-up. The funding is invested in Solutions with TRL 7+ and [or in the process of] CE marking, covering two modes: single players (EU Tech SMEs / Start-Ups) validating their solutions at one of COVID-X clinical partners; or multiplayers (Tech Provider working with a Healthcare provider that will validate the solution). Moreover, the selected projects will follow an Acceleration Program offering technical support, ethical advice and business mentoring, which will boost their quick market uptake.
The program is launching 2 Open Calls and the first Open Call will be launched in early December with a deadline at the end of January 2021.